In the fight against cancer, the Robert Bosch Center for Tumor Diseases focuses on combining scientific research and clinical application. As part of the Robert Bosch Center for Tumor Diseases, the Central Oncology Study Unit helps in rapidly implementing innovative projects in treatments. At the same time, clinical questions that arise during cancer treatment are taken back to science.
The Robert Bosch Center for Tumor Diseases is involved in numerous international studies and cooperates closely with university partners. Working together with Tübingen University Hospital, the Center is currently one of the top 13 oncological centers (Comprehensive Cancer Center Tübingen-Stuttgart) in Germany. In addition, the Robert Bosch Center for Tumor Diseases is a partner in the National Center for Tumor Diseases (NCT) South West, one of six sites across the country to receive 13 million euros a year in federal funding for innovation in the research and treatment of cancer.
The Robert Bosch Center for Tumor Diseases falls under the Robert Bosch Medical Research (RBMF), the umbrella organization for the different research facilities on site at the Bosch Health Campus. Here, research projects are funded almost exclusively by the Robert Bosch Stiftung.